Tag Archives: bladder cancer

As of September 2015, 97 percent of potential claimants have signed up to receive a portion of the $2.3 billion settlement that was announced in April 2015 between Takeda Pharmaceuticals and plaintiffs.

Takeda to Shell Out $2.4 Billion After 97% of Claimants Participate in Settlement

As of September 2015, 97% of potential claimants have signed up to receive a portion of the $2.3 billion settlement that was announced in April 2015 between Takeda Pharmaceuticals and plaintiffs claiming that Takeda’s diabetes drug Actos caused their bladder cancer. In the process of attracting claimants, Takeda settled 7 of the 9 cases that had already gone...
Read more

$6.5 Million Verdict Reinstated in First Actos Bladder Cancer Trial

The first product liability trial over claims that Takeda Pharmaceutical’s diabetes drug Actos caused bladder cancer was tossed out of court more than two years ago, but a California appeal court recently ruled to reinstate a $6.5 million jury award against the Japanese drug company. On July 16, 2015, the appeals court held...

Read more

Real Time Analytics